Johnson & Johnson said Friday it has received a binding offer from Platinum Equity to acquire its LifeScan business for about $2.1 billion. LifeScan is a blood glucose monitoring system with 2017 revenue of about $1.5 billion. If the offer is accepted by a June 15 deadline, the company expects to close the deal before year-end. Shares were flat in premarket trade, but have gained 3.8% in the last 12 months, while the S&P 500 has gained 15%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News